Deal of The Day! Hurry Up, Grab the Special Discount - Save 25% - Ends In 00:00:00 Coupon code: SAVE25
Welcome to Pass4Success

- Free Preparation Discussions

AHIP AHM-540 Exam - Topic 5 Question 25 Discussion

Actual exam question for AHIP's AHM-540 exam
Question #: 25
Topic #: 5
[All AHM-540 Questions]

The Noble Health Plan conducted a cost/benefit analysis of the following four prescription drugs:

Benefit Cost

Drug A $525 $350

Drug B $450 $250

Drug C $400 $200

Drug D $350 $100

According to this analysis, the drug that represents the most efficient use of resources is

Show Suggested Answer Hide Answer
Suggested Answer: D

Contribute your Thoughts:

0/2000 characters
Cristina
5 months ago
Drug B has a solid ratio too, don’t overlook it!
upvoted 0 times
...
Maryanne
5 months ago
Drug D is the cheapest option, though.
upvoted 0 times
...
Teddy
5 months ago
Wait, are we sure Drug A is the best? What about long-term effects?
upvoted 0 times
...
Tonette
5 months ago
Totally agree, Drug A is the clear winner here!
upvoted 0 times
...
Omer
5 months ago
Drug A has the highest benefit-to-cost ratio.
upvoted 0 times
...
Rhea
6 months ago
Okay, I've got this. An "except for" qualified opinion is appropriate when there is a scope limitation or a departure from GAAP that is material but not pervasive. An adverse opinion is for when the financial statements are materially and pervasively misstated. So in this case, I'd look for the situation that meets that adverse opinion criteria.
upvoted 0 times
...
Mickie
6 months ago
This seems like a straightforward Scrum of Scrums question. I'm pretty confident I can handle this.
upvoted 0 times
...

Save Cancel